Status:

COMPLETED

Repetitive Transcranial Magnetic Stimulation to People With Cannabis Use Disorder (SToP-C-rTMS x CUD)

Lead Sponsor:

The University of Hong Kong

Conditions:

Cannabis Use Disorder

Repetitive Transcranial Magnetic Stimulation

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

This study is to explore if repetitive transcrinal magnetic stimulation (rTMS) with different stimulation schedules will be equally effective in reducing carving, frequency of cannabis use, and the se...

Eligibility Criteria

Inclusion

  • Able to read and communicate in English and/or Chinese SToP-C-rTMS x CUD
  • Able to give informed consent
  • Using cannabis or marijuana as the primary psychoactive substance of abuse
  • Diagnosed with Cannabis Use Disorder according to the Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5) by the Structured Clinical Interview for DSM-5 Disorders (SCID-5)

Exclusion

  • Age \<18 years old
  • Unable to read English or Chinese
  • Unable to give informed consent
  • Had been diagnosed with the following disorders, including neurodevelopmental disorders, DSM-5 defined substance use disorder greater than moderate in severity, and neurocognitive disorders
  • Contra-indicated to have rTMS, including subjects with electronic and/or magnetic implants (e.g. pacemaker, implantable cardioverter defibrillator \[ICD\], cerebral shunts, cochlear implant, etc.), with metallic or mechanic fragments (e.g., screws, plates, stents, clips, etc.), pregnant, with any known or history of neurological conditions including cerebral vascular accidents, epilepsy, brain tumor or space occupying lesion, poorly controlled or unstable diabetes mellitus, and receiving unstable dose(s) of antipsychotics, antidepressants, benzodiazepines and/or anticonvulsants in the past 6 months

Key Trial Info

Start Date :

September 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2025

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05292547

Start Date

September 1 2022

End Date

March 31 2025

Last Update

July 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Queen Mary Hospital

Hong Kong, Hong Kong, 000000